Role of integrated PET-CT in pelvic lymph node staging of cervical cancer before radical hysterectomy

Gynecologic and Obstetric Investigation

Volumn 67, Issue 1, 2009, Pages 61-66

  Chung, Hyun Hoon ^a   Park, Noh Hyun ^a   Kim, Jae Weon ^a   Song, Yong Sang ^a   Chung, June Key ^a   Kang, Soon Beom ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Cervical cancer; PET CT; Prediction; Preoperative staging; Recurrence

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; HUMAN; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER;

ADULT; AGED; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 53249138392     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000162101     Document Type: Article

References (31)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-156.
2. Ministry of Health and Welfare, Korea 2002. Annual report of Korea Central Cancer Registry. Seoul, Ministry of Health and Welfare, 2003.
3. Eifel PJ BJ, Thigpen JT: Cancer of the Cervix, Vagina and Vulva, ed 5. Philadelphia, Lippincott-Raven, 1997.
4. Piver MS, Rutledge F, Smith JP: Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974;44:265-272.
5. Ishikawa H, Nakanishi T, Inoue T, Kuzuya K: Prognostic factors of adenocarcinoma of the uterine cervix. Gynecol Oncol 1999;73:42-46.
6. Kjorstad KE, Kolbenstvedt A, Strickert T: The value of complete lymphadenectomy in radical treatment of cancer of the cervix, Stage IB. Cancer 1984;54:2215-2219.
7. Noguchi H, Shiozawa I, Sakai Y, Yamazaki T, Fukuta T: Pelvic lymph node metastasis of uterine cervical cancer. Gynecol Oncol 1987;27:150-158.
8. Inoue T, Morita K: The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer 1990;65:1923-1927.
9. Girardi F, Haas J: The importance of the histologic processing of pelvic lymph nodes in the treatment of cervical cancer. Int J Gynecol Cancer 1993;3:12-17.
10. Sakuragi N, Satoh C, Takeda N, Hareyama H, Takeda M, Yamamoto R, et al: Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 1999;85:1547-1554.
11. Michel G, Morice P, Castaigne D, Leblanc M, Rey A, Duvillard P: Lymphatic spread in stage Ib and II cervical carcinoma: anatomy and surgical implications. Obstet Gynecol 1998;91:360-363.
12. Charron M, Beyer T, Bohnen NN, Kinahan PE, Dachille M, Jerin J, et al: Image analysis in patients with cancer studied with a combined PET and CT scanner. Clin Nucl Med 2000;25:905-910.
13. Kluetz PG, Meltzer CC, Villemagne VL, Kinahan PE, Chander S, Martinelli MA, et al: Combined PET/CT imaging in oncology. Impact on patient management. Clin Positron Imaging 2000;3:223-230.
14. Makhija S, Howden N, Edwards R, Kelley J, Townsend DW, Meltzer CC: Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review. Gynecol Oncol 2002;85:53-58.
15. Dizendorf EV, Treyer V, Von Schulthess GK, Hany TF: Application of oral contrast media in coregistered positron emission tomography-CT. AJR Am J Roentgenol 2002;179:477-481.
16. Cook GJ, Fogelman I, Maisey MN: Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positronemission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996;26:308-314.
17. Shreve PD, Anzai Y, Wahl RL: Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61-77; quiz, pp 150-151.
18. Nakamoto Y, Saga T, Ishimori T, Mamede M, Togashi K, Higuchi T, et al: Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. AJR Am J Roentgenol 2001;176:1449-1454.
19. Sugawara Y, Eisbruch A, Kosuda S, Recker BE, Kison PV, Wahl RL: Evaluation of FDG PET in patients with cervical cancer. J Nucl Med 1999;40:1125-1131.
20. Narayan K, Hicks RJ, Jobling T, Bernshaw D, McKenzie AF: A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment. Int J Gynecol Cancer 2001;11:263-271.
21. Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, Ihling C, Hogerle S, Mix M, et al: Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 2001;218:776-782.
22. Yildirim Y, Sehirali S, Avci ME, Yilmaz C, Ertopcu K, Tinar S, et al: Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings. Gynecol Oncol 2008;108:154-159.
23. 18F-FDG PET imaging in the management of cervical cancer. Gynecol Oncol 2002;87:90-97.
24. Williams AD, Cousins C, Soutter WP, Mubashar M, Peters AM, Dina R, et al: Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography. AJR Am J Roentgenol 2001;177:343-348.
25. Rohren EM, Turkington TG, Coleman RE: Clinical applications of PET in oncology. Radiology 2004;231:305-332.
26. Grigsby PW, Dehdashti F, Siegel BA: FDG-PET Evaluation of carcinoma of the cervix. Clin Positron Imaging 1999;2:105-109.
27. Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F: Positron emission tomography for evaluating paraaortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol 1999;17:41-45.
28. Grigsby PW, Siegel BA, Dehdashti F: Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 2001;19:3745-3749.
29. Choi HJ, Roh JW, Seo SS, Lee S, Kim JY, Kim SK, et al: Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer 2006;106:914-922.
30. Chung HH, Jo H, Kang WJ, Kim JW, Park NH, Song YS, et al: Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence. Gynecol Oncol 2007;104:529-534.
31. Sironi S, Buda A, Picchio M, Perego P, Moreni R, Pellegrino A, et al: Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 2006;238:272-279.